INS and obesity due to melanocortin 4 receptor deficiency: Studies have demonstrated improvements in glycaemic control in cases of obesity and diabetes mellitus [91], reduced insulin requirements [31], and halted disease progression in recently diagnosed type-1 diabetics by preserving endogenous insulin production [32].